About This Business

Hanson Wade is a leading organizer of specialized events and conferences in the field of cytokine-based drug development. The company brings together influential leaders and experts from top biotechnology and pharmaceutical companies to discuss and address the challenges and opportunities in the development of cytokine-based therapies. Their events, such as the Cytokine-Based Drug Development Summit, provide a platform for intimate discussions, interactive workshops, and presentations to drive innovation and break down barriers associated with systemic toxicity. By improving the specificity and delivery of cytokine-based drugs, Hanson Wade's events help influence the future of immunotherapy. With a strong network of partners, including Candel, Deka Biosciences, Regeneron, Sanofi, ModeX, and OSE, Hanson Wade is at the forefront of advancing cytokine-based therapies and facilitating collaboration among key stakeholders. The company's expertise and commitment to the field have made it a trusted name in the industry, and its events are highly anticipated by professionals seeking to stay updated on the latest developments and advancements in cytokine-based drug development. As the field continues to evolve, Hanson Wade remains dedicated to providing a platform for knowledge sharing, innovation, and progress, ultimately contributing to the development of more effective and targeted treatments for various diseases.